Effectiveness of individualized homoeopathic medicines vs. Sabadilla in the treatment of upper respiratory tract infections in children: An open-label randomized pragmatic clinical trial

ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1. Preadolescent children (1-11 years of age)
•2. Clinical signs and symptoms of an URTI with a duration of up to 24 hours accompanied with or without fever 37.5áµ?C (axillary body temperature) or higher
•3. At least 1 of 3 types of URTI symptoms â?? Nasal (plugged nose, runny nose, sneezing), Pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), Cough (ordinary cough without suspicion of acute lower respiratory tract disease).
•4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active

•1. Severe or complicated course of URTI.
•2. Signs of acute lower respiratory tract disease.
•3. Current symptoms mainly induced by other acute ENT diseases.
•4. Daily use of antibiotics, steroids and cytotoxic agents.
•5. Children on active treatment from any other system of medicine.
•6. Children with any uncontrolled systemic disease, infection, and any organ failure.
•7. Severe co morbidity including previous malignant disease during the past 5 years prior enrolment.

发起方

ational Institute of Homoeopathy Ministry of AYUSH Govt of India